Date:- From 2021-05-06 to 2021-05-07
Connect and meet us during this conference.
Our “Pharma” BD team will participate to organize B2B meeting.
Do not miss HalioDx’s workshop on May 6th, 2021 at 4 pm. In this workshop, HalioDx will present next-generation biomarker strategies for immuno-oncology translational research & clinical trials:
- TMExplore, multiomic approach to understanding the TME, including Brightplex®: a validated brightfield multiplex IHC platform
- Immunogram®,an innovative multimodal 360° biomarker analysis platform dedicated to immuno oncology focused research programs